No Data
ARS Pharmaceuticals(SPRY.US) 10% Shareholder Sells US$913.92K in Common Stock
$ARS Pharmaceuticals(SPRY.US)$ 10% Shareholder Tanimoto Sarina sold 100K shares of common stock on Jun 11, 12, 2024 at an average price of $9.1392 for a total value of $913.92K. This transaction invol
Ars Pharmaceuticals Insider Sold Shares Worth $913,917, According to a Recent SEC Filing
Richard E Lowenthal, 10% Owner, Director, President and CEO, on June 11, 2024, sold 100,000 shares in Ars Pharmaceuticals (SPRY) for $913,917. Following the Form 4 filing with the SEC, Lowenthal has c
Form 144 | ARS Pharmaceuticals(SPRY.US) Officer Proposes to Sell 2.7 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 11, $ARS Pharmaceuticals(SPRY.US)$ Officer Lowenthal Richard E intends to sell 300K shares of its common stock on Jun 11, with a total market value of approximately $2.7 mi
ARS Pharmaceuticals(SPRY.US) 10% Shareholder Sells US$905.44K in Common Stock
$ARS Pharmaceuticals(SPRY.US)$ 10% Shareholder Lowenthal Richard E sold 100K shares of common stock on May 14, 15, 16, 2024 at an average price of $9.0544 for a total value of $905.44K. This transacti
Analysts Have Conflicting Sentiments on These Healthcare Companies: ARS Pharmaceuticals (SPRY), AnaptysBio (ANAB) and Allakos (ALLK)
ARS Pharmaceuticals Inc (SPRY) Q1 2024 Earnings: Aligns With EPS Projections Amidst Regulatory ...